70720-101 : Varubi 90 mg Oral Tablet
| NDC: | 70720-101 |
| Labeler: | Tersera Therapeutics LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Varubi |
| Dosage Form: | Oral Tablet |
| Application #: | NDA206500 |
| Rev. Date: |
Appearance:
| Markings: | T0101;100 |
| Shapes: |
Oval |
| Colors: |
 Blue |
| Size (mm): | 15 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 70720-101-02: 2 TABLET IN 1 BLISTER PACK (70720‑101‑02)
Active Ingredients:
- Rolapitant Hydrochloride
Dosage Strength:
- 90 mg
Inactive Ingredients:
- Lactose Monohydrate
- Starch, Corn
- Microcrystalline Cellulose
- Povidone, Unspecified
- Croscarmellose Sodium
- Silicon Dioxide
- Magnesium Stearate
- Polyvinyl Alcohol, Unspecified
- Titanium Dioxide
- Polyethylene Glycol, Unspecified
- Talc
- Fd&c Blue No. 2
- Polysorbate 80 /
Pharmaceutical Classes:
- Neurokinin 1 Antagonists [MoA]
- Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- Cytochrome P450 2D6 Inhibitors [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 69656-101 Varubi 90 mg Oral Tablet by Tesaro, Inc.
- 69656-102 Varubi 1.8 mg/ml Intravenous Injection, Emulsion by Tesaro, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70720-100Next: 70720-115 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.